Related Experiment Videos
Sentinel lymph node detection and microstaging in vulvar carcinoma.
K L Molpus1, M C Kelley, J E Johnson
1Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198-3255, USA. kmolpus@unmc.edu
The Journal of Reproductive Medicine
|December 1, 2001
Summary
Combined techniques improve sentinel lymph node (SLN) detection in vulvar cancer. Histologic microstaging further enhances the identification of micrometastases in SLNs, crucial for accurate cancer staging.
Area of Science:
- Oncology
- Surgical Pathology
- Medical Imaging
Background:
- Vulvar carcinoma diagnosis and staging rely on accurate assessment of lymph node involvement.
- Sentinel lymph node detection (SLND) is critical for staging and guiding treatment in vulvar cancer.
- Microstaging techniques can improve the sensitivity of detecting minimal metastatic disease.
Purpose of the Study:
- To evaluate the efficacy of combined complementary techniques for sentinel lymph node (SLN) detection in vulvar carcinoma.
- To assess the utility of microstaging for identifying micrometastases in SLNs.
Main Methods:
- Patients with invasive vulvar carcinoma underwent SLND using lymphoscintigraphy, isosulfan blue dye, and a gamma-detecting probe.
- Sentinel nodes were examined using hematoxylin and eosin (H&E) staining.
- Pathologically negative SLNs were further analyzed with serial sectioning and immunohistochemistry for cytokeratin.
Main Results:
- Combined-modality mapping achieved high SLN detection rates.
- Isosulfan blue dye identified an additional SLN in two cases.
- Histologic microstaging detected micrometastases in 11% of initially negative SLNs.
Conclusions:
- Combined-modality mapping significantly enhances SLN detection in vulvar carcinoma.
- Histologic microstaging is essential for improving the detection of micrometastases within SLNs, refining cancer staging.